Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
- PMID: 32552792
- PMCID: PMC7301053
- DOI: 10.1186/s12883-020-01812-2
Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
Abstract
Background: COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2. It is widely recognized as a respiratory pathogen, but neurologic complications can be the presenting manifestation in a subset of infected patients.
Case presentation: We describe a 78-year old immunocompromised woman who presented with altered mental status after witnessed seizure-like activity at home. She was found to have SARS-CoV-2 infection and associated neuroinflammation. In this case, we undertake the first detailed analysis of cerebrospinal fluid (CSF) cytokines during COVID-19 infection and find a unique pattern of inflammation in CSF, but no evidence of viral neuroinvasion.
Conclusion: Our findings suggest that neurologic symptoms such as encephalopathy and seizures may be the initial presentation of COVID-19. Central nervous system inflammation may associate with neurologic manifestations of disease.
Keywords: COVID-19; Neuroinflammation; SARS-CoV-2.
Conflict of interest statement
The authors report no competing interests.
Figures



Update of
-
Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19.Res Sq [Preprint]. 2020 May 12:rs.3.rs-28583. doi: 10.21203/rs.3.rs-28583/v1. Res Sq. 2020. Update in: BMC Neurol. 2020 Jun 18;20(1):248. doi: 10.1186/s12883-020-01812-2. PMID: 32702723 Free PMC article. Updated. Preprint.